Biomarin

[video] The Next Big Thing In Biotech: Ligand, BioMarin & Sangamo
TheStreet.com
Fri, 11/30/12 - 12:11 pm
Biomarin
Sangamo BioSciences
Ligand
Alnylam Pharmaceuticals, BioMarin Pharmaceutical Inc., and Cytonet Set to Speak on Conducting Effective Orphan Drug Research
CP Wire
Fri, 11/16/12 - 10:27 am
Alnylam
Cytonet
Biomarin
orphan drugs
Biotech Weekend Recap: Important Developments And Big Releases
Seeking Alpha
Sun, 11/11/12 - 09:49 am
Amarin
Vivus
Dendreon
Arena Pharmaceuticals
Pharmacyclics
Biomarin
This Week in Biotech: Part 1
Motley Fool
Sun, 11/11/12 - 09:17 am
Novartis
Novo Nordisk
Corcept Therapeutics
Biomarin
Sequenom
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 11/10/12 - 08:19 am
Biomarin
InterMune
Idenix
Buyout Buzz: The most frequently cited takeover targets in biotech
Fierce Biotech
Tue, 11/6/12 - 04:32 pm
biotech
M&A
Amarin
Achillion
ONYX Pharmaceuticals
Actelion
Elan
Forest Labs
Medivation
Biomarin
Indenix
BioMarin at life-high as genetic disorder drug meets main goal
Reuters
Mon, 11/5/12 - 12:58 pm
Biomarin
GALNs
Morquio A Syndrome
BioMarin Earnings: 3 Keys from Q3
Motley Fool
Mon, 10/29/12 - 02:44 pm
earnings
Biomarin
BioMarin Reports Narrower Loss
Yahoo/Zacks
Sat, 10/27/12 - 11:31 am
Biomarin
earnings
BioMarin Pharmaceuticals Inc (BMRN): Today's Featured Drugs Winner
The Street
Sat, 10/6/12 - 11:25 am
Biomarin
AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence
Seekin Alpha
Mon, 10/1/12 - 09:52 pm
M&A
AstraZeneca
Seattle Genetics
Regeneron
ONYX Pharmaceuticals
Biomarin
Forest Labs
Pipeline Progress at BioMarin
Zacks
Sat, 09/29/12 - 12:36 pm
BMN-111
Peg-Pal
dwarfism
phenylketonuria
Biomarin
Twin Orphan Drug News
Motley Fool
Sat, 09/29/12 - 11:50 am
Biomarin
orphan drugs
Peg-Pal
phenylketonuria
Kuvan
Biomarin: Four Clinical Trial Events to Watch Before Year End
TheStreet.com
Tue, 09/25/12 - 11:27 am
Biomarin
BMN-111
GALNs
BMRN-763
Peg-Pal
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
Tue, 08/28/12 - 11:07 am
Cell Therapeutics
Momenta
Onyx
Amag Pharmaceuticals
Biomarin
M&A
Celgene
Seattle Genetics
Galena Biopharma
ImmunoCellular
Amgen
Celldex
Dendreon
GSK
Vical
Oncothyreon
Biogen Idec
Merck KGaA
Bristol-Myers Squibb
Allos
Spectrum Pharmaceuticals
AstraZeneca
arclays Starts BioMarin Pharmaceutical Inc. (BMRN) at Overweight; Three Shots on Goal
Street Insider
Sat, 08/25/12 - 12:50 pm
Biomarin
3 High-Growth Biotech Stocks With Encouraging Inventory Trends
Seeking Alpha
Tue, 08/21/12 - 11:33 am
Biomarin
China Biologic
Anika
BioMarin Pharmaceuticals Inc: Today's Featured Health Care Laggard
The Street
Sat, 08/11/12 - 12:03 pm
Biomarin
Bio Buyouts
Motley Fool
Sun, 07/29/12 - 12:10 pm
Seattle Genetics
Alexion
Regeneron
Biomarin
Vertex Pharmaceuticals
Idenix
Obagi Medical Products
3 Healthcare Mid Caps With Strong EPS Growth Projections And Analyst Backing
Seeking Alpha
Fri, 07/27/12 - 11:55 am
Vivus
Biomarin
Alkermes

Pages